Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.

News Releases

view all
    • News in Focus
        • Browse News Releases

        • All Public Company News
        • All Multimedia News
        • View All News Releases

        • Regulatory News

        • D/A/CH Regulatory News
        • UK Regulatory News
        • View All Regulatory News

    • Business & Money
        • Auto & Transportation

        • Aerospace & Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads & Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking & Road Transportation
        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers & Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalisation
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls & Research
        • Trade Show News
        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil & Gas Discoveries
        • Utilities
        • Water Utilities
        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defence
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation & Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking & Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers & Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines & Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics & Personal Care
        • Fashion
        • Food & Beverages
        • Furniture & Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewellery
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • View All Sports

        • Travel

        • Amusement Parks & Tourist Attractions
        • Gambling & Casinos
        • Hotels & Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Animal Welfare
        • Corporate Social Responsibility
        • Economic News, Trends & Analysis
        • Education
        • Environmental
        • European Government
        • Labour & Union
        • Natural Disasters
        • Not For Profit
        • Public Safety
        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Enquiries
    • Media Enquiries
    • Partnerships
    • Hamburger menu
    • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
    • Send a Release
      • Phone

      • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

      • ALL CONTACT INFO
      • Contact Us

        +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • 2 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • General Enquiries
      • Media Enquiries
      • Partnerships
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Regulatory News
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Veterinary Biologics Market worth $3.69 billion by 2031 - Exclusive Report by MarketsandMarkets™

      This image opens in the lightbox

      News provided by

      MarketsandMarkets

      20 Nov, 2026, 15:45 GMT

      Share this article

      Share this article


      DELRAY BEACH, Fla., Nov. 20, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Veterinary Biologics Market is projected to reach USD 3.69 billion by 2031 from USD 2.85 billion in 2026, at a CAGR of 5.3% during the forecast period.

      Browse 380 market data Tables and 80 Figures spread through 500 Pages and in-depth TOC on 'Veterinary Biologics Market - Global Forecast to 2031'

      Anatomic Pathology Market Size & Forecast:

      • Market Size Available for Years: 2026–2031
      • 2026 Market Size: USD 2.85 billion
      • 2031 Projected Market Size: USD 3.69 billion
      • CAGR (2026–2031): 5.3%

      Veterinary Biologics Market Trends & Insights:

      • By region, North America is anticipated to record the highest CAGR between 2026 and 2031.
      • By product, the monoclonal antibodies segment accounted for 58.2% of the market in 2025.
      • By application, the dermatology segment is expected to register the highest CAGR of 5.7% during the forecast period.
      • By end user, the veterinary hospitals & clinics segment is projected to witness the highest CAGR of 5.8% during the forecast period.

      Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=4768999

      The global veterinary biologics market is expanding as chronic diseases such as atopic dermatitis and osteoarthritis pain become more common in pets. This rising prevalence of chronic diseases is driving demand for novel treatment options. Moreover, growing awareness of pet health and wellness is further driving demand for better veterinary care worldwide.

      By product type, the monoclonal antibodies segment is expected to grow at the fastest rate in the global veterinary biologics market during the forecast period.

      By animal type, the monoclonal antibodies segment is expected to grow rapidly in the veterinary biologics market, driven by their targeted mechanism of action, high efficacy, and growing adoption in livestock health management. These biologics are increasingly used to prevent and treat specific diseases by precisely targeting pathogens or toxins, offering a more selective and effective alternative to traditional therapies, such as antibiotics. In livestock applications, monoclonal antibodies are particularly valuable for conditions requiring rapid immune support, leading to reduced morbidity and improved productivity. Their use supports the global shift toward sustainable animal farming practices and the reduction of antimicrobial resistance (AMR), positioning them as a preferred choice for advanced biologic interventions.

      By application, the dermatology segment accounted for the largest share of the global veterinary biologics market.

      The dermatology segment is expected to hold the largest share of the veterinary biologics market, driven by the rising prevalence of skin disorders in companion and livestock animals, including allergies, bacterial and fungal infections, and parasitic infestations. Increasing pet ownership and growing awareness of animal health are driving demand for advanced biologics, including vaccines, immunotherapies, and monoclonal antibodies for dermatological conditions. Innovations in biologics that offer long-term efficacy with minimal side effects are further boosting adoption. Moreover, rising expenditure on animal healthcare, coupled with the expansion of veterinary clinics and hospitals, is fueling this segment's growth. Additionally, the availability of targeted biologics for chronic skin conditions is expected to enhance treatment outcomes. Together, these factors position dermatology as the leading application segment in the veterinary biologics market.

      Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=137323145

      By region, North America accounted for the largest share during the forecast period.

      The region's rapid market expansion is driven by a growing pet population, rising awareness of animal health, and increased spending on veterinary care. Additionally, advanced veterinary healthcare infrastructure and the presence of key market players are further driving growth in countries such as China, India, and Japan. Livestock farming also plays a significant role in the region's economy. Countries such as India and China have large numbers of livestock, driven by rising demand for meat, milk, and other animal-based products.

      Key Players

      Leading players in the Veterinary Biologics companies include Zoetis Services LLC (US), IDEXX (US), Elanco (US), Merck & Co., Inc. (US), Thermo Fisher Scientific Inc. (US), Boehringer Ingelheim International GmbH (Germany), Neogen Corporation (US), Bio-Rad Laboratories, Inc. (US), ImmuCell Corporation (US), and Innovative Diagnostics (France).

      Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=4768999

      Veterinary Biologics Market - Investment and Funding Scenario

      Investment Funding Context

      The global veterinary biologics market is seeing investment activity driven by acquisitions, biotechnology innovation, and the expansion of veterinary antibody and diagnostic platforms. The global veterinary biologics market is witnessing investment activity driven by acquisitions, biotechnology innovation, and expansion of veterinary antibody and diagnostic platforms. Funding declined from USD 740 million in 2021 to USD 530 million in 2022 before recovering to USD 610 million in 2023 and USD 720 million in 2024. In 2025, funding was estimated to increase to approximately USD 780 million, reflecting continued investment in veterinary biotechnology, monoclonal antibody development, innovative vaccines, and diagnostic platforms. These figures represent broader animal-health investment trends rather than funding exclusively attributable to veterinary biologics. The recovery in funding and deal activity reflects continued interest in veterinary biologics, though these aggregate figures should be treated as market-wide investment indicators rather than as funding attributable exclusively to veterinary biologics.

      Revenue Shift Context

      The global veterinary biologics market is projected to grow from USD 2.85 billion in 2026 to USD 3.69 billion by 2031, at a CAGR of 5.3%. Growth is expected to be supported by advances in monoclonal antibodies, immunoglobulins, antitoxins, immunomodulators, immunostimulants, and diagnostic kits. Investment in antibody-based therapies for companion animals, vaccines and biologics for livestock, and molecular diagnostic technologies is creating new opportunities for product development and commercialization. Established animal-health companies are expanding their portfolios through acquisitions and partnerships to access specialized biotechnology platforms, strengthen research pipelines, and develop next-generation veterinary biologics.

      Mergers and Acquisitions

      Mergers and acquisitions in the veterinary biologics market for 2025 are on pace to exceed 2024 volume, with a rising share of deals valued as buyers prioritize mature, platform-ready assets.

      VETERINARY BIOLOGICS MARKET: MERGERS AND ACQUISITIONS, JANUARY 2023–OCTOBER 2026

      Month & Year

      Deal Type

      Company 1

      Company 2

      Description

      February 2026

      Merger agreement

      Covetrus (US)

      MWI Animal Health (US)

      Covetrus and MWI Animal Health announced a definitive agreement to merge their animal-health distribution and technology businesses.

      November 2025

      Acquisition

      Zoetis Inc. (US)

      Veterinary Pathology Group (UK)

      Zoetis acquired Veterinary Pathology Group, a veterinary diagnostic laboratory group operating in the UK and Ireland. The acquisition expanded Zoetis' diagnostic capabilities and strengthened its support for veterinary disease detection and clinical decision-making

      September 2024

      Acquisition

      Boehringer Ingelheim (Germany)

      Saiba Animal Health AG (Switzerland)

      Boehringer Ingelheim acquired Saiba Animal Health, gaining access to a therapeutic-vaccine platform designed to stimulate immune responses against disease-associated proteins. The acquisition strengthened its research capabilities in innovative treatments for chronic diseases in companion animals.

      Company Revenue Share Details

      The global veterinary biologics market is highly consolidated, with the top five players accounting for an estimated 79.0–86.0% of the market. Leading companies benefit from established veterinary distribution networks, substantial research and development capabilities, broad product portfolios, and regulatory expertise. Key players include Zoetis Inc. (US), Merck & Co., Inc. (US), Boehringer Ingelheim International GmbH (Germany), Elanco Animal Health Incorporated (US), and Ceva Santé Animale (France). These companies compete across veterinary vaccines, monoclonal antibodies, immunoglobulins and antitoxins, immunomodulators and immunostimulants, and related biologic products. Their established commercial presence and investments in innovative therapies strengthen their competitive positions, while acquisitions of specialized biotechnology companies create opportunities to expand product pipelines and address emerging animal health needs.

      Browse Adjacent Market: Medical Devices Market Research Reports &Consulting

      See More Latest Medical Devices Reports:

      Veterinary Diagnostics Market by Technology (PCR, ELISA, Lateral Flow Assay, Molecular Diagnostics, Immunodiagnostics), Product (Consumables, Instruments), Animal (Companion, Livestock, Swine), Application (Infectious, Bacteria) - Global Forecast to 2030

      Veterinary Infectious Disease Diagnostics Market by Product (Consumables, Instruments), Technology (Molecular Diagnostic, PCR, ELISA, Immunodiagnostics, Rapid Tests), Animal Type (Companion Animal, Livestock), End User & Region - Global Forecast to 2030

      About MarketsandMarkets™

      MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

      MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

      Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

      The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

      Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

      MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

      To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

      Contact:
      Mr. Rohan Salgarkar
      MarketsandMarkets™ INC.
      1615 South Congress Ave.
      Suite 103, Delray Beach, FL 33445
      USA: +1-888-600-6441
      Email: sales@marketsandmarkets.com
      Visit Our Website: https://www.marketsandmarkets.com/
      Research Insight: https://www.marketsandmarkets.com/ResearchInsight/veterinary-biologics-companies.asp
      Content Source: https://www.marketsandmarkets.com/PressReleases/veterinary-biologics.asp

      Modal title

      Also from this source

      Label Free Detection Market worth $0.85 billion by 2031 - Exclusive Report by MarketsandMarkets™

      Label Free Detection Market worth $0.85 billion by 2031 - Exclusive Report by MarketsandMarkets™

      According to MarketsandMarkets™, the Label Free Detection Market is projected to reach USD 0.85 billion by 2031 from USD 0.58 billion in 2026, at a...

      Explosion Proof Valve Market worth $1.74 billion by 2032 - Exclusive Report by MarketsandMarkets™

      Explosion Proof Valve Market worth $1.74 billion by 2032 - Exclusive Report by MarketsandMarkets™

      According to MarketsandMarkets™, the Explosion Proof Valve Market is projected to grow from USD 1.38 billion in 2026 to USD 1.74 billion by 2032,...

      More Releases From This Source

      Explore

      Biotechnology

      Biotechnology

      Health Care & Hospitals

      Health Care & Hospitals

      Animal Welfare

      Animal Welfare

      Animals & Pets

      Animals & Pets

      News Releases in Similar Topics

      Contact PR Newswire

      • +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT
      • General Enquiries
      • Media Enquiries
      • Partnerships

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United States
      • Vietnam

      My Services

      • All News Releases
      • PR Newswire Amplify™
      • Resources
      • Journalists
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via Privacy@cision.com 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Customer Portal
      • Resources
      • Journalists
      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookie Settings
      Copyright © 2026 PR Newswire Europe Limited. All Rights Reserved. A Cision company.